Current role of bevacizumab in colorectal cancer
Saltz, L.
Clinical Advances in Hematology and Oncology H&o 7(6): 375-376
2009
ISSN/ISBN: 1543-0790 PMID: 19606071 Document Number: 634988
Document emailed within 1 workday
Related Documents
Soga, Y.; Ito, D.; Asano, H.; Go, M.; Iwai, M.; Okada, K.; Matsuoka, T.; Adachi, S.; Usami, E.; Kimura, M.; Nakao, T.; Yoshimura, T.; Yasuda, T.; Ogawa, T.; Iwaki, A. 2013: Continuation of chemotherapy with bevacizumab for advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1341-1345Matsumoto, R.; Kuroda, T.; Yamada, H.; Hasegawa, K.; Mamiya, Y.; Kon, A. 2009: Chemotherapy with bevacizumab (BV)+modified FOLFOX6 for unresectable colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2207-2209
Hasegawa, J.; Noura, S.; Hirota, M.; Matsumura, T.; Yasuyama, A.; Takata, A.; Koga, C.; Murakami, M.; Kameda, C.; Oda, N.; Kawabata, R.; Morishima, H.; Shimizu, J.; Matsunami, N. 2016: A Case of Metastatic Colorectal Cancer Refractory to Standard Chemotherapies Treated with TAS-102 with Bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 2289-2291
Maruo, H.; Suzuki, K.; Ishikawa, S.; Murakami, T.; Higashi, Y.; Shoji, T.; Yamazaki, M.; Taniguchi, M.; Nishiyama, R. 2014: Study of S-1 and oxaliplatin(SOX) plus bevacizumab as first-line therapy in patients with unresectable colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(13): 2583-2586
Koike, J.; Ushigome, M.; Funahashi, K.; Shiokawa, H.; Kaneko, T.; Arai, K.; Matsuda, S.; Kagami, S.; Suzuki, T.; Kurihara, A.; Shimada, H.; Kaneko, H. 2014: Significance of KRAS mutation in patients receiving mFOLFOX6 with or without bevacizumab for metastatic colorectal cancer Hepato-Gastroenterology 61(136): 2222-2226
Arakawa, S.; Horiguchi, A.; Tomishige, H.; Kawabe, N.; Nagata, H.; Ishihara, S.; Ito, M.; Asano, Y.; Ito, R.; Isetani, M.; Shimizu, K.; Kamio, K.; Kawai, T.; Yasuoka, H.; Imaeda, Y. 2018: Safety and Efficacy of TAS-102 with Bevacizumab for the Treatment of Unresectable Metastatic Colorectal Cancer - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(4): 649-651
Chen, C.; Sun, P.; Ye, S.; Weng, H.-W.; Dai, Q.-S. 2014: Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: a meta-analysis Journal of Buon: Official Journal of the Balkan Union of Oncology 19(4): 917-924
Takano, J.; Matsuhashi, N.; Takahashi, T.; Tanahashi, T.; Matsui, S.; Imai, H.; Tanaka, Y.; Yamaguchi, K.; Yoshida, K. 2018: A Case of Metastatic Colorectal Cancer with Brain Metastasis Treated with Combined TFTD and Bevacizumab Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 318-320
Takeda, T.; Miyake, M.; Tanaka, K.; Uemura, M.; Ikeda, M.; Maeda, S.; Yamamoto, K.; Hama, N.; Nishikawa, K.; Miyamoto, A.; Miyazaki, M.; Hirao, M.; Nakamori, S.; Sekimoto, M. 2015: XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1594-1596
Imaizumi, H.; Ishibashi, K.; Okada, N.; Tajima, Y.; Amano, K.; Hatano, S.; Kuwabara, K.; Sobajima, J.; Ishiguro, T.; Ohsawa, T.; Kumamoto, K.; Kumagai, Y.; Haga, N.; Ishida, H. 2012: Clinical outcomes in refractory colorectal cancer patients with wild-type K-ras treated with bevacizumab and oxaliplatin-based chemotherapy as a first-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2185-2188
Sehnalová, I.; Říhová, B.; Demlová, R. 2019: Bevacizumab treatment in metastatic colorectal carcinoma - an economic perspective Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 68(2): 43-47
Armitage, N. 1997: Current management of colorectal cancer Practitioner 241(1572): 146-150
Carlsen, E. 2000: Current treatment of colorectal cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(23): 2738
Grem, J.L. 1991: Current treatment approaches in colorectal cancer Seminars in Oncology 18(1 Suppl. 1): 17-26
Hasegawa, H.; Nishibori, H.; Ishii, Y.; Kitajima, M. 2004: Current status on laparoscopic surgery for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(5): 685-689
Chang, D.Z. 2007: The current status of vaccine development in colorectal cancer Clinical Advances in Hematology and Oncology: H&o 5(2): 109-111; 136
O'Connell, M.J. 2004: Current status of adjuvant therapy for colorectal cancer Oncology 18(6): 751
Trojan, J. 2011: Colorectal cancer--current screening, treatment and follow-up standards Versicherungsmedizin 63(3): 132-136
Halámková, J.; Tomášek, J.; Rybníčková, S.; Adámková Krákorová, D.; Bencsiková, B.; Kiss, I. 2013: The current approach to the treatment of the patients with metastatic colorectal cancer Vnitrni Lekarstvi 59(10): 903-908
Otsuka, Y.; Itabashi, T.; Fujisawa, K.; Akiyama, Y.; Sasaki, A.; Ikeda, K.; Wakabayashi, T. 2007: Current status and problems in laparoscopic surgery for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(11): 1764-1767